메뉴 건너뛰기
Aktuelle Neurologie
Volumn 35, Issue 2, 2008, Pages 85-88
Myasthenia centres - Recommendations for standardisation;Myasthenie-zentren - Empfehlungen zu ihrer standardisierung
Author keywords

Diagnosis; Guidelines; Myasthenia centres; Myasthenia gravis; Treatment
Indexed keywords

ARTICLE; EUROPE; HUMAN; KNOWLEDGE; MYASTHENIA GRAVIS; PATIENT CARE; PHYSICIAN; STANDARDIZATION;
EID: 41349123314     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-986297     Document Type: Article
Times cited : (3)
References (17)
  • 1
    • 0034880988 scopus 로고    scopus 로고
    • Epidemiology of seropositive myasthenia gravis in Greece
    • Poulas K, Tsibri E, Kokla A et al. Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 2001; 71: 352-356
    • (2001) J Neurol Neurosurg Psychiatry , vol.71 , pp. 352-356
    • Poulas, K.1    Tsibri, E.2    Kokla, A.3
  • 2
    • 34447640717 scopus 로고    scopus 로고
    • Myasthenia gravis: Aktuelle Aspekte der Pathogenese, Diagnostik und Therapie.
    • Dörr J, Zipp F. Myasthenia gravis: Aktuelle Aspekte der Pathogenese, Diagnostik und Therapie. Nervenheilkunde 2007; 26: 587-595
    • (2007) Nervenheilkunde , vol.26 , pp. 587-595
    • Dörr, J.1    Zipp, F.2
  • 3
    • 0038354017 scopus 로고    scopus 로고
    • The neuromuscular junction disorders
    • Hill M. The neuromuscular junction disorders. J Neurol Neurosurg Psychiatry 2003; 74: II32-II37
    • (2003) J Neurol Neurosurg Psychiatry , vol.74
    • Hill, M.1
  • 5
    • 0035666702 scopus 로고    scopus 로고
    • Pearls and Pitfalls in the Diagnosis and Management of Neuromuscular Junction Disorders
    • Pascuzzi R. Pearls and Pitfalls in the Diagnosis and Management of Neuromuscular Junction Disorders. Seminars in Neurology 2001; 21: 425-440
    • (2001) Seminars in Neurology , vol.21 , pp. 425-440
    • Pascuzzi, R.1
  • 6
    • 33847412291 scopus 로고    scopus 로고
    • Myasthenia gravis: Pathogenese und Immuntherapie
    • Schneider-Gold C, Toyka KV. Myasthenia gravis: Pathogenese und Immuntherapie. Dtsch Ärztebl 2007; 104: 368-375
    • (2007) Dtsch Ärztebl , vol.104 , pp. 368-375
    • Schneider-Gold, C.1    Toyka, K.V.2
  • 7
    • 14344264862 scopus 로고    scopus 로고
    • Aktuelle Aspekte in der Pathogenese, Diagnostik und Therapie der Myasthenia gravis
    • Jander S, Hartung H-P. Aktuelle Aspekte in der Pathogenese, Diagnostik und Therapie der Myasthenia gravis. Akt Neurol 2005; 32: 3-9
    • (2005) Akt Neurol , vol.32 , pp. 3-9
    • Jander, S.1    Hartung, H.-P.2
  • 8
    • 0347994922 scopus 로고    scopus 로고
    • Treatment of autoimmune myasthenia gravis
    • Richman DP, Agius MA. Treatment of autoimmune myasthenia gravis. Neurology 2003; 61: 1652-1661
    • (2003) Neurology , vol.61 , pp. 1652-1661
    • Richman, D.P.1    Agius, M.A.2
  • 10
    • 1842478034 scopus 로고    scopus 로고
    • Clinical evaluation and management of myasthenia gravis
    • Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve 2004; 29: 484-505
    • (2004) Muscle Nerve , vol.29 , pp. 484-505
    • JC, K.1
  • 11
    • 33746534220 scopus 로고    scopus 로고
    • Guidelines for the treatment of autoimmune neuromuscular transmission disorders
    • Skeie GO, Apostolski S, Evoli A et al. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2006; 13: 691-699
    • (2006) Eur J Neurol , vol.13 , pp. 691-699
    • Skeie, G.O.1    Apostolski, S.2    Evoli, A.3
  • 12
    • 0031851956 scopus 로고    scopus 로고
    • Gemeinsame Stellungnahme zur Notwendigkeit von speziellen Myasthenie-Sprechstunden.
    • S
    • Köhler W, Janzen RWC, Kunze K, Hertel G. Gemeinsame Stellungnahme zur Notwendigkeit von speziellen Myasthenie-Sprechstunden. Akt Neurol 1998; 25: S 52
    • (1998) Akt Neurol , vol.25 , pp. 52
    • Köhler, W.1    Janzen, R.W.C.2    Kunze, K.3    Hertel, G.4
  • 13
    • 0020513595 scopus 로고
    • Myasthenia gravis: Long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity
    • Besinger UA, Toyka KV, Hömberg M et al. Myasthenia gravis: Long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 1983; 33: 1316-1321
    • (1983) Neurology , vol.33 , pp. 1316-1321
    • Besinger, U.A.1    Toyka, K.V.2    Hömberg, M.3
  • 14
    • 0022001231 scopus 로고
    • Klinisches Bewertungssystem (Score) der oculären Symptome bei Myasthenia gravis.
    • Schumm F, Dichgans J. Klinisches Bewertungssystem (Score) der oculären Symptome bei Myasthenia gravis. Nervenarzt 1985; 56: 186-187
    • (1985) Nervenarzt , vol.56 , pp. 186-187
    • Schumm, F.1    Dichgans, J.2
  • 15
    • 10944242649 scopus 로고    scopus 로고
    • Treatment review and update for myasthenia gravis
    • Wolfe GI, Gross B. Treatment review and update for myasthenia gravis. Clin Neuromuscular disease 2004; 6: 54-68
    • (2004) Clin Neuromuscular disease , vol.6 , pp. 54-68
    • Wolfe, G.I.1    Gross, B.2
  • 16
    • 41349116903 scopus 로고    scopus 로고
    • Cholinergika
    • Hrsg, Neurologische Pharmakotherapie. Stuttgart, New York: Thieme
    • Schumm F. Cholinergika. In: Fox JM, Jörg J (Hrsg): Neurologische Pharmakotherapie. Stuttgart, New York: Thieme, 2004: 191-220
    • (2004) Fox JM, Jörg J , pp. 191-220
    • Schumm, F.1
  • 17
    • 27744586691 scopus 로고    scopus 로고
    • Treatment of Myasthenia gravis exacerbation with intravenous Immunoglobulin
    • Gajdos P, Trauchant C, Clair B et al. Treatment of Myasthenia gravis exacerbation with intravenous Immunoglobulin. Arch Neurol 2005; 62: 1689-1693
    • (2005) Arch Neurol , vol.62 , pp. 1689-1693
    • Gajdos, P.1    Trauchant, C.2    Clair, B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.